Ewing sarcoma is a highly aggressive small round cell malignant neoplasm of bone and soft tissue that typically is manifested in children and young adults. It is most commonly a primary bone tumor; however, extraosseous cases have been increasingly reported. We report a case of metastatic extraosseous Ewing sarcoma with the primary lesion occurring within a limb affected by primary lymphedema. Lymphedema, in this case, played a role not only in the genesis of the tumor because of the relative local immunosuppression but also in masking the development of the lower limb mass. (J Vasc Surg Cases and Innovative Techniques 2018;4:210-5.) Keywords: Ewing sarcoma; Lymphedema; Lymphatic disorders; Histopathology; Oncology; Radiology Ewing sarcoma is a highly aggressive small round cell malignant neoplasm of bone and soft tissue that typically is manifested in children and young adults. 1 In the majority of patients (w90%), a translocation t(11;22) between the Ewing sarcoma breakpoint region 1 (EWSR1) and the Friend leukemic integration 1 (FLI1) genes is seen, producing the EWS-FLI1 chimeric fusion oncogene. 2, 3 In addition, CD99 antigen is strongly expressed on the cell membrane in Ewing sarcoma and represents a sensitive although nonspecific immunohistochemical marker.
Ewing sarcoma is a highly aggressive small round cell malignant neoplasm of bone and soft tissue that typically is manifested in children and young adults. 1 In the majority of patients (w90%), a translocation t (11;22) between the Ewing sarcoma breakpoint region 1 (EWSR1) and the Friend leukemic integration 1 (FLI1) genes is seen, producing the EWS-FLI1 chimeric fusion oncogene. 2, 3 In addition, CD99 antigen is strongly expressed on the cell membrane in Ewing sarcoma and represents a sensitive although nonspecific immunohistochemical marker. 1 Ewing sarcoma is most commonly a primary bone tumor; however, extraosseous primary tumors are documented to represent up to 31% in a large-scale analysis of the U.S. National Cancer Institute's Surveillance, Epidemiology and End Results database, with both having similar patient outcomes. 4 The most common extraosseous sites include the torso, paravertebral regions, limbs, retroperitoneum, and head and neck. 1, 5 Five-year overall survival for localized disease is 65% to 75%, whereas <30% is reported for extensive metastatic disease. 6 This report outlines a case of extraosseous Ewing sarcoma in a patient with primary lymphedema of the left leg. Informed consent was obtained before publication.
CASE REPORT
A 34-year-old man presented to the emergency department the morning after developing sudden-onset left-sided pleuritic chest pain and shortness of breath. Six months previously, a large parapneumonic effusion had been drained, followed by a video-assisted thoracoscopic surgical pleurodesis. The pathologic examination of the pleural fluid did not show any signs of malignancy, and computed tomography (CT) of the chest did not show any pulmonary lesions. In this 6-month period, (Fig 2, D) . Findings on CT of the brain and testicular ultrasound were unremarkable. Carcinoembryonic antigen, cancer antigen 19-9, a-fetoprotein, and b-human chorionic gonadotropin were all within normal limits.
Fine-needle aspiration of a pleura-based lesion showed scattered tumor cells with a high nuclear to cytoplasmic ratio, primitive-looking nuclei with slightly irregular nuclear outlines, nuclear molding, and cytoplasmic vacuolation, all features reminiscent of Ewing sarcoma (Fig 3) . Flow cytometry was unremarkable. Core biopsies of the same lesion showed sheets of small tumor cells, with some arranged in a circular fashion resembling rosettes (Fig 4) . There was weak patchy reactivity with antibody to synaptophysin and moderate to strong membranous reactivity with antibody to CD99. Endothelial markers CD31 and CD34 stained vessels present in the core biopsy sections but 
DISCUSSION
Given the recent history of weight loss and probable recurrent pulmonary emboli, malignant neoplasm was thought the most likely underlying disease process, and the initial impression was that of a primary metastatic pancreatic tumor. The histopathologic findings from a pleura-based lesion were surprising, suggesting sarcoma and favoring Ewing sarcoma. Before the results of the fluorescent in situ hybridization, which ultimately detected the FLI1-EWSR1 rearrangement, a PET scan was performed to assist in diagnosis and to plan treatment. This revealed the occult primary within the lymphedematous limb, which had been given less attention because of its chronicity and the focus on the chest and abdominal findings. In retrospect, the thrombus visualized in the left iliac vein on CT of the abdomen was likely tumor thrombus.
Extraosseous Ewing sarcoma is consistently reported as a rare presentation; however, it does represent approximately one-third of cases. Features of extraosseous tumors in contrast to osseous include the following: patients are less likely to be male (no gender predilection); overall survival is poorer in the first 24 months; overall survival is improved beyond 24 months; and average age at onset is later (bimodal distribution, more commonly found in patients younger than 5 years and older than 35 years). 4 Signs and symptoms are dependent on the site of origin 7 and tend to be due to space-occupying effects, such as pain and swelling. 8 Local control is best achieved with surgery, which should be performed whenever a marginal or wide resection is achievable. 6 Amputations are rarely indicated (<10% of cases) but may be used in inoperable lesions if radiotherapy is predicted to lead to a poor functional outcome because of tumor location or patient factors. 6 Case reports of extraosseous Ewing sarcoma of varying locations (eg, leg, 9 spinal, 10 intracranial, 11 and intra-abdominal 7 ) indicate positive outcomes after surgery and adjuvant chemotherapy with or without radiotherapy, although follow-up has been limited to <2 years. The thigh is a reasonably common site for extraosseous Ewing sarcoma 8 ; however, evidence of long-term outcomes in the literature is lacking. The fact that the primary tumor in this case arose within a lymphedematous limb is significant, as the chronic condition masked the presence of a mass lesion. Lymphedema may be primary, which may or may not be congenital, or secondary to surgery (eg, lymph node dissection or vein harvesting), chronic bacterial or parasitic infection, irradiation, trauma, or lymphoma. 12 Lymphedema produces local immunosuppression as a result of lymphatic fluid stasis and the relative upregulation of growth factors within the microenvironment. 13 This is thought to be associated with the potential development of malignant disease. 12 The most common malignant neoplasms reported to occur in the context of chronic lymphedema are angiosarcoma and lymphangiosarcoma, with >400 documented cases. 12 Other tumors arising within lymphedematous regions include Kaposi sarcoma, nonmelanoma skin cancer, melanoma, and cutaneous lymphoma. 12 Single case reports have also identified porocarcinoma after vein harvesting 14 and breast surgery, 15 fibrous histiocytoma, 16 and Merkel cell carcinoma. 17 To the best of our knowledge, there have been no reported cases of Ewing sarcoma arising within a lymphedematous region. Ewing sarcoma has been sporadically reported to arise within immunocompromised patients, including after renal transplantation, 18 in children with human immunodeficiency virus infection, 19 and as a secondary malignant neoplasm after treatment for hematologic and solid malignant neoplasms. 20 Primary lymphedema, congenital or acquired, is associated with a higher albeit rare increased risk of a number of different malignant neoplasms, including angiosarcoma, Kaposi sarcoma, B-cell lymphoma, 21 and, as demonstrated in this case, Ewing sarcoma. As such, a high index of suspicion is needed because patients will not have the usual clinical findings of a palpable mass. Any significant change in symptoms, especially pain or an increase in swelling, should be thoroughly investigated, including imaging of the limb with CT or magnetic resonance imaging. Early diagnosis and early surgical intervention with or without radiotherapy for local control combined with multiagent chemotherapy are critical to improve patient outcomes, given significantly poorer overall survival associated with metastatic disease.
